411 related articles for article (PubMed ID: 26460949)
1. Rescuing lymphocytes from HLA-G immunosuppressive effects mediated by the tumor microenvironment.
Wu D; Kuiaste I; Moreau P; Carosella E; Yotnda P
Oncotarget; 2015 Nov; 6(35):37385-97. PubMed ID: 26460949
[TBL] [Abstract][Full Text] [Related]
2. Human Leukocyte Antigen-G Inhibits the Anti-Tumor Effect of Natural Killer Cells via Immunoglobulin-Like Transcript 2 in Gastric Cancer.
Wan R; Wang ZW; Li H; Peng XD; Liu GY; Ou JM; Cheng AQ
Cell Physiol Biochem; 2017; 44(5):1828-1841. PubMed ID: 29224003
[TBL] [Abstract][Full Text] [Related]
3. First immunotherapeutic CAR-T cells against the immune checkpoint protein HLA-G.
Anna F; Bole-Richard E; LeMaoult J; Escande M; Lecomte M; Certoux JM; Souque P; Garnache F; Adotevi O; Langlade-Demoyen P; Loustau M; Caumartin J
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737343
[TBL] [Abstract][Full Text] [Related]
4. TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.
Lelaidier M; Dìaz-Rodriguez Y; Cordeau M; Cordeiro P; Haddad E; Herblot S; Duval M
Oncotarget; 2015 Oct; 6(30):29440-55. PubMed ID: 26320191
[TBL] [Abstract][Full Text] [Related]
5. HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.
Morel E; Bellón T
J Immunol; 2008 Aug; 181(4):2368-81. PubMed ID: 18684926
[TBL] [Abstract][Full Text] [Related]
6. Cytometry-based analysis of HLA-G functions according to ILT2 expression.
Jacquier A; Dumont C; Carosella ED; Rouas-Freiss N; LeMaoult J
Hum Immunol; 2020 Apr; 81(4):168-177. PubMed ID: 32081570
[TBL] [Abstract][Full Text] [Related]
7. NK cytolysis is dependent on the proportion of HLA-G expression.
Chen BG; Xu DP; Lin A; Yan WH
Hum Immunol; 2013 Mar; 74(3):286-9. PubMed ID: 23238216
[TBL] [Abstract][Full Text] [Related]
8. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts.
Zhang W; Liang S; Wu J; Horuzsko A
Transplantation; 2008 Oct; 86(8):1125-34. PubMed ID: 18946352
[TBL] [Abstract][Full Text] [Related]
9. Increased frequency of ILT2-expressing CD56(dim)CD16(+) NK cells correlates with disease severity of pulmonary tuberculosis.
Wang X; Meng X; Zheng Y; Jiang J; Yang B; Liu Y; Zhai F; Cheng X
Tuberculosis (Edinb); 2014 Sep; 94(5):469-74. PubMed ID: 24909369
[TBL] [Abstract][Full Text] [Related]
10. A bispecific protein rG7S-MICA recruits natural killer cells and enhances NKG2D-mediated immunosurveillance against hepatocellular carcinoma.
Wang T; Sun F; Xie W; Tang M; He H; Jia X; Tian X; Wang M; Zhang J
Cancer Lett; 2016 Mar; 372(2):166-78. PubMed ID: 26791237
[TBL] [Abstract][Full Text] [Related]
11. A Phenotypic Analysis of Regulatory T Cells and Uterine NK Cells from First Trimester Pregnancies and Associations with HLA-G.
Djurisic S; Skibsted L; Hviid TV
Am J Reprod Immunol; 2015 Nov; 74(5):427-44. PubMed ID: 26293482
[TBL] [Abstract][Full Text] [Related]
12.
Guo X; Mahlakõiv T; Ye Q; Somanchi S; He S; Rana H; DiFiglia A; Gleason J; van der Touw W; Hariri R; Zhang X
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741730
[TBL] [Abstract][Full Text] [Related]
13. ILT2/HLA-G interaction impairs NK-cell functions through the inhibition of the late but not the early events of the NK-cell activating synapse.
Favier B; Lemaoult J; Lesport E; Carosella ED
FASEB J; 2010 Mar; 24(3):689-99. PubMed ID: 19841038
[TBL] [Abstract][Full Text] [Related]
14. CD8
Dumont C; Jacquier A; Verine J; Noel F; Goujon A; Wu CL; Hung TM; Desgrandchamps F; Culine S; Carosella ED; Rouas-Freiss N; LeMaoult J
Cancer Immunol Res; 2019 Oct; 7(10):1619-1632. PubMed ID: 31451484
[TBL] [Abstract][Full Text] [Related]
15. Continuously expanding CAR NK-92 cells display selective cytotoxicity against B-cell leukemia and lymphoma.
Oelsner S; Friede ME; Zhang C; Wagner J; Badura S; Bader P; Ullrich E; Ottmann OG; Klingemann H; Tonn T; Wels WS
Cytotherapy; 2017 Feb; 19(2):235-249. PubMed ID: 27887866
[TBL] [Abstract][Full Text] [Related]
16. Blocking transforming growth factor-β signaling pathway augments antitumor effect of adoptive NK-92 cell therapy.
Yang B; Liu H; Shi W; Wang Z; Sun S; Zhang G; Hu Y; Liu T; Jiao S
Int Immunopharmacol; 2013 Oct; 17(2):198-204. PubMed ID: 23806302
[TBL] [Abstract][Full Text] [Related]
17. Chimeric antigen receptor engineered NK cellular immunotherapy overcomes the selection of T-cell escape variant cancer cells.
Lee MY; Robbins Y; Sievers C; Friedman J; Abdul Sater H; Clavijo PE; Judd N; Tsong E; Silvin C; Soon-Shiong P; Padget MR; Schlom J; Hodge J; Hinrichs C; Allen C
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33741731
[TBL] [Abstract][Full Text] [Related]
18. HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells.
LeMaoult J; Zafaranloo K; Le Danff C; Carosella ED
FASEB J; 2005 Apr; 19(6):662-4. PubMed ID: 15670976
[TBL] [Abstract][Full Text] [Related]
19. HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization.
Baudhuin J; Lesport E; Sousa S; Migraine J; Vigneron J; Lemaoult J; Carosella ED; Mooney N; Favier B
Eur J Immunol; 2012 Mar; 42(3):700-9. PubMed ID: 22144141
[TBL] [Abstract][Full Text] [Related]
20. Neoplastic B-cell growth is impaired by HLA-G/ILT2 interaction.
Naji A; Menier C; Maki G; Carosella ED; Rouas-Freiss N
Leukemia; 2012 Aug; 26(8):1889-92. PubMed ID: 22441169
[No Abstract] [Full Text] [Related]
[Next] [New Search]
